
WHO approves emergency use of China’s Sinopharm COVID vaccine
Al Jazeera
Sinopharm is the first COVID jab developed by a non-Western country to win World Heath Organization backing.
The World Health Organization has approved the emergency use of a COVID-19 vaccine manufactured by China’s Sinopharm. Friday’s decision by a WHO technical advisory group, a first for a Chinese vaccine, opens the possibility that Sinopharm’s offering could be included in the United Nations-backed COVAX programme in coming weeks or months, and distributed through United Nations children’s agency UNICEF and WHO’s Americas regional office. Aside from efficacy numbers, the Chinese manufacturer has released very little public data about its two vaccines – one developed by its Beijing Institute of Biological Products and the other by the Wuhan Institute of Biological Products.More Related News